KeyBank National Association’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $652K | Hold |
46,515
| – | – | ﹤0.01% | 687 |
|
|
2025
Q1 | $727K | Sell |
46,515
-5,689
| -11% | -$89K | ﹤0.01% | 627 |
|
|
2024
Q4 | $727K | Buy |
52,204
+9,680
| +23% | +$135K | ﹤0.01% | 649 |
|
|
2024
Q3 | $395K | Hold |
42,524
| – | – | ﹤0.01% | 879 |
|
|
2024
Q2 | $395K | Hold |
42,524
| – | – | ﹤0.01% | 831 |
|
|
2024
Q1 | $421K | Buy |
42,524
+7,300
| +21% | +$72.3K | ﹤0.01% | 817 |
|
|
2023
Q4 | $114K | Buy |
35,224
+22,195
| +170% | +$71.7K | ﹤0.01% | 1058 |
|
|
2023
Q3 | $69.2K | Hold |
13,029
| – | – | ﹤0.01% | 1016 |
|
|
2023
Q2 | $124K | Buy |
+13,029
| New | +$124K | ﹤0.01% | 1033 |
|